SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438833
Filing Date
2013-11-13
Accepted
2013-11-12 20:17:24
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d614851d10q.htm 10-Q 510726
2 EX-31.1 d614851dex311.htm EX-31.1 8765
3 EX-31.2 d614851dex312.htm EX-31.2 8727
4 EX-32.1 d614851dex321.htm EX-32.1 3850
5 EX-32.2 d614851dex322.htm EX-32.2 3999
  Complete submission text file 0001193125-13-438833.txt   3501295

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lpcn-20130930.xml EX-101.INS 503890
7 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20130930.xsd EX-101.SCH 28722
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20130930_cal.xml EX-101.CAL 24315
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20130930_def.xml EX-101.DEF 164554
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20130930_lab.xml EX-101.LAB 205854
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20130930_pre.xml EX-101.PRE 197153
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55092 | Film No.: 131212060
SIC: 2834 Pharmaceutical Preparations